Home » Topics » Regulatory

Regulatory
RSS

5-LO inhibitor approved by FDA

Dec. 13, 1996

First approval for Pharmacyclics' MRI contrast agent

Dec. 12, 1996

NMDA antagonists ameliorate ototoxicity of aminoglycoside antibiotics

Dec. 12, 1996

Janssen files for lower-dose risperidone in U.S.

Dec. 12, 1996

Cholesterol-lowering statin approved in first markets

Dec. 11, 1996

OsmoCyte approved for marketing in U.S.

Dec. 9, 1996

Cytovene approved for new indication in U.S.

Dec. 6, 1996

Once-daily antihypertensive combination cleared for marketing in Canada

Dec. 3, 1996

First approval for Aricept

Nov. 27, 1996

Water-soluble fiber introduced in first market for high cholesterol

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026